{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:24:59Z","timestamp":1778743499150,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>We assumed that in Palliative Care, even in common clinical situations, the choice of drugs differs substantially between physicians. Therefore, we assessed the practice of pharmaceutical treatment choices of physicians for cancer pain and opioid-induced nausea and vomiting (OINV) and the rationale for their choices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An online survey was conducted with physicians covering the following domains: i) Cancer pain therapy: non-opioids in addition to opioids: choice of drug ii) prevention of OINV: choice of drug and mode of application. Current guidelines concerning cancer pain therapy and prevention of OINV were compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two-hundred-forty European physicians responded to our survey. i) Use of non-opioids in addition to opioids for the treatment of cancer pain: Only 1.3% (n\u2009=\u20093) of respondents never used an additional non-opioid. Others mostly used: dipyrone\/metamizole (49.2%, n\u2009=\u2009118), paracetamol\/acetaminophen (34.2%, n\u2009=\u200982), ibuprofen \/ other NSAIDs (11.3%, n\u2009=\u200927), specific Cox2-inhibitors (2.1%, n\u2009=\u20095), Aspirin (0.4%, n\u2009=\u20091), no answer (2.9%, n\u2009=\u20097). ii) Antiemetics to prevent OINV: The drugs of choice were metoclopramide (58.3%, n\u2009=\u2009140), haloperidol (26.3%, n\u2009=\u200963), 5-HT3 antagonists (9.6%, n\u2009=\u200923), antihistamines (1.3%, n\u2009=\u20093) and other (2.9%, n\u2009=\u20097); no answer (1.7%, n\u2009=\u20094). Most respondents prescribed the substances on-demand (59.6%, n\u2009=\u2009143) while others (36.3%, n\u2009=\u200987) provided them as around the clock medication. Over both domains, most physicians answered that their choices were not based on solid evidence from randomized controlled trials (RCTs). Guidelines were inconsistent regarding if and what non-opioid to use for cancer pain and recommend anti-dopaminergic drugs for prevention or treatment of OINV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Physician\u2019s practice in palliative care for the treatment of cancer pain and OINV differed substantially. Respondents expressed the lack of high-quality evidence- based information from RCTs. We call for evidence from methodologically high-quality RCTs to be available to inform physicians about the benefits and harms of pharmacological treatments for common symptoms in palliative care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-024-08628-7","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:01:28Z","timestamp":1718485288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacological treatment of cancer\u00a0pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1176-3164","authenticated-orcid":false,"given":"Jan","family":"Gaertner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-0201","authenticated-orcid":false,"given":"Christopher","family":"Boehlke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0674-7079","authenticated-orcid":false,"given":"Gudrun","family":"Kreye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6270-1035","authenticated-orcid":false,"given":"Tanja","family":"Fusi-Schmidhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-6558","authenticated-orcid":false,"given":"Evelyn","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-5842","authenticated-orcid":false,"given":"Carmen","family":"Roch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"8628_CR1","unstructured":"WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva: World Health Organization; 2018. 5, Cancer Pain Management \u2013 Guiding Principles. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537483\/"},{"issue":"11","key":"8628_CR2","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1007\/s00520-020-05370-8","volume":"28","author":"W Siemens","year":"2020","unstructured":"Siemens W, Boehlke C, Bennett MI, Offner K, Becker G, Gaertner J (2020) Transcutaneous electrical nerve stimulation for advanced cancer pain inpatients in specialist palliative care-a blinded, randomized, sham-controlled pilot cross-over trial. Support Care Cancer 28(11):5323\u20135333. https:\/\/doi.org\/10.1007\/s00520-020-05370-8","journal-title":"Support Care Cancer"},{"issue":"1","key":"8628_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12032-023-02238-9","volume":"41","author":"SP Bianchi","year":"2023","unstructured":"Bianchi SP, Faccenda V, Pacifico P, Parma G, Saufi S, Ferrario F et al (2023) Short-term pain control after palliative radiotherapy for uncomplicated bone metastases: a prospective cohort study. Med Oncol 41(1):13. https:\/\/doi.org\/10.1007\/s12032-023-02238-9","journal-title":"Med Oncol"},{"issue":"46","key":"8628_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3238\/arztebl.2015.0788","volume":"112","author":"M Warth","year":"2015","unstructured":"Warth M, Ke\u00dfler J, Hillecke TK, Bardenheuer HJ (2015) Music Therapy in Palliative Care. Dtsch Arztebl Int 112(46):788\u2013794. https:\/\/doi.org\/10.3238\/arztebl.2015.0788","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"8628_CR5","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1007\/s00520-021-06248-z","volume":"29","author":"M Thron\u00e6s","year":"2021","unstructured":"Thron\u00e6s M, L\u00f8hre ET, Kvikstad A, Brenne E, Norvaag R, Aalberg KO et al (2021) Interventions and symptom relief in hospital palliative cancer care: results from a prospective longitudinal study. Support Care Cancer 29(11):6595\u20136603. https:\/\/doi.org\/10.1007\/s00520-021-06248-z","journal-title":"Support Care Cancer"},{"issue":"9784","key":"8628_CR6","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/s0140-6736(11)60236-5","volume":"377","author":"RK Portenoy","year":"2011","unstructured":"Portenoy RK (2011) Treatment of cancer pain. Lancet 377(9784):2236\u20132247. https:\/\/doi.org\/10.1016\/s0140-6736(11)60236-5","journal-title":"Lancet"},{"issue":"9","key":"8628_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437\u20131449. https:\/\/doi.org\/10.1093\/annonc\/mdm056","journal-title":"Ann Oncol"},{"issue":"12","key":"8628_CR8","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","volume":"19","author":"S Deandrea","year":"2008","unstructured":"Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain A review of published literature. Ann Oncol 19(12):1985\u201391. https:\/\/doi.org\/10.1093\/annonc\/mdn419","journal-title":"Ann Oncol"},{"key":"8628_CR9","unstructured":"World Health Organization (2023)Palliative care. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/palliative-care. Accessed 14 Jan 2024"},{"key":"8628_CR10","unstructured":"Vargas-Schaffer G. (2010) Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 56(6):514\u20137, e202\u20135"},{"issue":"4","key":"8628_CR11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1526-4637.2009.00583.x","volume":"10","author":"F Porreca","year":"2009","unstructured":"Porreca F, Ossipov MH (2009) Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. Pain Med 10(4):654\u2013662. https:\/\/doi.org\/10.1111\/j.1526-4637.2009.00583.x","journal-title":"Pain Med"},{"issue":"2","key":"8628_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18773\/austprescr.2020.011","volume":"43","author":"A Athavale","year":"2020","unstructured":"Athavale A, Athavale T, Roberts DM (2020) Antiemetic drugs: what to prescribe and when. Aust Prescr 43(2):49\u201356. https:\/\/doi.org\/10.18773\/austprescr.2020.011","journal-title":"Aust Prescr"},{"issue":"10","key":"8628_CR13","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","volume":"36","author":"A Sharma","year":"2021","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS et al (2021) A Consensus-Based Checklist for Reporting of Survey Studies (CROSS). J Gen Intern Med 36(10):3179\u201387. https:\/\/doi.org\/10.1007\/s11606-021-06737-1","journal-title":"J Gen Intern Med"},{"issue":"Suppl 4","key":"8628_CR14","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M et al (2018) Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 29(Suppl 4):iv166\u2013iv91. https:\/\/doi.org\/10.1093\/annonc\/mdy152","journal-title":"Ann Oncol"},{"issue":"4","key":"8628_CR15","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/jco.22.02198","volume":"41","author":"JA Paice","year":"2023","unstructured":"Paice JA, Bohlke K, Barton D, Craig DS, El-Jawahri A, Hershman DL et al (2023) Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. J Clin Oncol 41(4):914\u2013930. https:\/\/doi.org\/10.1200\/jco.22.02198","journal-title":"J Clin Oncol"},{"key":"8628_CR16","unstructured":"German Guideline Programme in Oncology (German Cancer Society, German Cancer Aid, AWMF) (2020) Palliative care for patients with incurable cancer, long version 2.2, AWMF-registration number 128\/001OL. Available from: https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/palliativmedizin\/. Accessed 15 Jan 2024"},{"issue":"2","key":"8628_CR17","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/s1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N et al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58-68. https:\/\/doi.org\/10.1016\/s1470-2045(12)70040-2","journal-title":"Lancet Oncol"},{"issue":"5","key":"8628_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jcpt.12422","volume":"41","author":"S Andrade","year":"2016","unstructured":"Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J (2016) Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther 41(5):459\u2013477. https:\/\/doi.org\/10.1111\/jcpt.12422","journal-title":"J Clin Pharm Ther"},{"key":"8628_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4366","volume":"347","author":"S Bhaumik","year":"2013","unstructured":"Bhaumik S (2013) India\u2019s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen. BMJ 347:f4366. https:\/\/doi.org\/10.1136\/bmj.f4366","journal-title":"BMJ"},{"issue":"6","key":"8628_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/bf00278592","volume":"38","author":"F Arellano","year":"1990","unstructured":"Arellano F, Sacrist\u00e1n JA (1990) Metamizole: reassessment of its therapeutic role. Eur J Clin Pharmacol 38(6):617\u2013619. https:\/\/doi.org\/10.1007\/bf00278592","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"8628_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpainsymman.2023.05.002","volume":"66","author":"O Leiva-V\u00e1squez","year":"2023","unstructured":"Leiva-V\u00e1squez O, Letelier LM, Rojas L, Viviani P, Castellano J, Gonz\u00e1lez A et al (2023) Is Acetaminophen Beneficial in Patients With Cancer Pain Who are on Strong Opioids? A Randomized Controlled Trial. J Pain Symptom Manage 66(3):183\u201392.e1. https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.05.002","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"8628_CR22","doi-asserted-by":"publisher","first-page":"CD012638","DOI":"10.1002\/14651858.CD012638.pub2","volume":"7","author":"S Derry","year":"2017","unstructured":"Derry S, Wiffen PJ, Moore RA, McNicol ED, Bell RF, Carr DB et al (2017) Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev 7(7):CD012638. https:\/\/doi.org\/10.1002\/14651858.CD012638.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"e1","key":"8628_CR23","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1136\/bmjspcare-2020-002792","volume":"13","author":"AJ Page","year":"2023","unstructured":"Page AJ, Mulvey MR, Bennett MI (2023) Designing a clinical trial of non-steroidal anti-inflammatory drugs for cancer pain: a survey of UK palliative care physicians. BMJ Support Palliat Care 13(e1):e55\u2013e58. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002792","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"8628_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0269216316655746","volume":"31","author":"J Gaertner","year":"2017","unstructured":"Gaertner J, Stamer UM, Remi C, Voltz R, Bausewein C, Sabatowski R et al (2017) Metamizole\/dipyrone for the relief of cancer pain: A systematic review and evidence-based recommendations for clinical practice. Palliat Med 31(1):26\u201334. https:\/\/doi.org\/10.1177\/0269216316655746","journal-title":"Palliat Med"},{"issue":"1","key":"8628_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12904-023-01291-5","volume":"23","author":"C Volberg","year":"2024","unstructured":"Volberg C, Schmidt-Semisch H, Maul J, Nadig J, Gschnell M (2024) Pain management in German hospices: a cross-sectional study. BMC Palliat Care 23(1):7. https:\/\/doi.org\/10.1186\/s12904-023-01291-5","journal-title":"BMC Palliat Care"},{"issue":"3","key":"8628_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1634\/theoncologist.2017-0225","volume":"23","author":"H Tsukuura","year":"2018","unstructured":"Tsukuura H, Miyazaki M, Morita T, Sugishita M, Kato H, Murasaki Y et al (2018) Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled Double-Blind Trial. Oncologist 23(3):367\u2013374. https:\/\/doi.org\/10.1634\/theoncologist.2017-0225","journal-title":"Oncologist"},{"issue":"3","key":"8628_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00520-001-0332-1","volume":"10","author":"J Hardy","year":"2002","unstructured":"Hardy J, Daly S, McQuade B, Albertsson M, Chimontsi-Kypriou V, Stathopoulos P et al (2002) A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer 10(3):231\u20136. https:\/\/doi.org\/10.1007\/s00520-001-0332-1","journal-title":"Support Care Cancer"},{"issue":"3","key":"8628_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/0310057x1003800311","volume":"38","author":"BK Huh","year":"2010","unstructured":"Huh BK, Jung S, White W, Jeon Y (2010) Anti-emetic effect of midazolam added to morphine patient-controlled analgesia after total abdominal hysterectomy. Anaesth Intensive Care 38(3):481\u2013485. https:\/\/doi.org\/10.1177\/0310057x1003800311","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"8628_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/jpm.2018.0260","volume":"22","author":"TA Sande","year":"2019","unstructured":"Sande TA, Laird BJA, Fallon MT (2019) The Management of Opioid-Induced Nausea and Vomiting in Patients with Cancer: A Systematic Review. J Palliat Med 22(1):90\u201397. https:\/\/doi.org\/10.1089\/jpm.2018.0260","journal-title":"J Palliat Med"},{"issue":"5","key":"8628_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/0269216311404273","volume":"25","author":"EA Laugsand","year":"2011","unstructured":"Laugsand EA, Kaasa S, Klepstad P (2011) Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliat Med 25(5):442\u2013453. https:\/\/doi.org\/10.1177\/0269216311404273","journal-title":"Palliat Med"},{"issue":"3","key":"8628_CR31","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G (2004) Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 6(3):e34. https:\/\/doi.org\/10.2196\/jmir.6.3.e34","journal-title":"J Med Internet Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08628-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:15:56Z","timestamp":1721034956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["8628"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08628-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"436"}}